<DOC>
	<DOCNO>NCT01150942</DOCNO>
	<brief_summary>To assess immunogenicity safety vero cell-derived inactivated JE vaccine Korean healthy child age 12~23 month</brief_summary>
	<brief_title>Clinical Trial Assess Immunogenicity Safety Vero Cell-derived JE Vaccine Korea</brief_title>
	<detailed_description>To compare Vero cell-derived inactivated Japanese encephalitis ( JE ) vaccine 'KD-287 ( JEIMMUGEN INJ . ) ' mouse brain-derived inactivated JE vaccine term immunogenicity safety , Korean healthy child age 12~23 month</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy child age 1223 month Written inform consent History document HIV Known suspect impairment immunologic function History serious chronic disease Received JE vaccine prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>JEV</keyword>
	<keyword>vero cell</keyword>
</DOC>